AquaBounty Technologies (AQB)

Overall impact
C (57)

Commentary

AquaBounty Technologies is an average overall performer. With a 'C' rating of 56.9 for overall impact (56th percentile compared to all companies), AquaBounty Technologies ranks 450th out of 585 industry peers, behind Biogen, Ionis Pharmaceuticals, Gilead Sciences and 446 others, and ahead of Grifols, Jazz Pharmaceuticals, Gb Sciences and 132 others. On top material causes for AquaBounty Technologies's industry (Pharmaceuticals & Biotech), AquaBounty Technologies performs well in Child and Maternal Health (93.9 score), Disease Eradication (96.5), Access to Affordable Healthcare (88.1) and 1 other cause where it received an 'A' score and performs poorly in Humane Treatment of Animals (30.4 score), Technology Innovation (33.9), Sustainable Use of Natural Resources (39.7) and 3 other causes where it received a 'D' or 'F' score.
Impact
Cause AQB
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
3
Sector
Health Care
Industry
Biotechnology
Sub-industry
Biotechnology
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Ma, United States
Share classes
AQB
Description
AquaBounty Technologies, Inc. operates as a land-based aquaculture company in the United States. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.
Material causes
Ethos considers the following causes material for AquaBounty Technologies, based on its industry sub-industry Biotechnology. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.